Audrey Le Gouëllec

Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.

J. Lenormand, B. Toussaint, B. Camara, 2018, Vaccine.

A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.

C. Aspord, C. Trocmé, B. Polack, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Bacterial vectors for active immunotherapy reach clinical and industrial stages

B. Polack, B. Toussaint, L. Buffat, 2012, Human vaccines & immunotherapeutics.

Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery

J. Marvel, B. Polack, B. Toussaint, 2016, Molecular therapy oncolytics.

Roles of Pneumococcal DivIB in Cell Division

T. Vernet, D. Fadda, O. Massidda, 2008, Journal of bacteriology.

In vitro reconstitution of a trimeric complex of DivIB, DivIC and FtsL, and their transient co‐localization at the division site in Streptococcus pneumoniae

T. Vernet, M. Noirclerc-Savoye, O. Dideberg, 2004, Molecular microbiology.

Central Domain of DivIB Caps the C-terminal Regions of the FtsL/DivIC Coiled-coil Rod*

T. Vernet, J. Simorre, F. Gabel, 2009, The Journal of Biological Chemistry.

Optimization of Antitumor Immunotherapy Mediated by Type III Secretion System-based Live Attenuated Bacterial Vectors

B. Polack, H. Chaker, B. Toussaint, 2012, Journal of immunotherapy.

Metabotypes of Pseudomonas aeruginosa Correlate with Antibiotic Resistance, Virulence and Clinical Outcome in Cystic Fibrosis Chronic Infections

J. Boccard, D. Bicout, F. Fenaille, 2021, Metabolites.